Details for New Drug Application (NDA): 203691
✉ Email this page to a colleague
The generic ingredient in TEMOZOLOMIDE is temozolomide. There are sixteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the temozolomide profile page.
Summary for 203691
Tradename: | TEMOZOLOMIDE |
Applicant: | Amneal Pharms |
Ingredient: | temozolomide |
Patents: | 0 |
Pharmacology for NDA: 203691
Mechanism of Action | Alkylating Activity |
Suppliers and Packaging for NDA: 203691
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 203691 | ANDA | AvPAK | 50268-761 | 50268-761-12 | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-761-12) / 1 CAPSULE in 1 BLISTER PACK (50268-761-11) |
TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 203691 | ANDA | AvPAK | 50268-762 | 50268-762-12 | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-762-12) / 1 CAPSULE in 1 BLISTER PACK (50268-762-11) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 5MG | ||||
Approval Date: | May 8, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 20MG | ||||
Approval Date: | May 8, 2015 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | May 8, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription